SGCE expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.880000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.905000E-01
Normal-vs-Stage2
4.258800E-01
Normal-vs-Stage3
7.120800E-01
Normal-vs-Stage4
8.829000E-01
Stage1-vs-Stage2
5.557600E-01
Stage1-vs-Stage3
8.939600E-01
Stage1-vs-Stage4
9.275000E-01
Stage2-vs-Stage3
7.801400E-01
Stage2-vs-Stage4
5.276400E-01
Stage3-vs-Stage4
8.469800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.190800E-01
Normal-vs-AfricanAmerican
8.948200E-01
Normal-vs-Asian
8.607800E-02
Caucasian-vs-AfricanAmerican
6.103800E-01
Caucasian-vs-Asian
5.480500E-02
AfricanAmerican-vs-Asian
5.020200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.725000E-01
Normal-vs-Female
7.593000E-01
Male-vs-Female
1.167200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.844800E-01
Normal-vs-Age(41-60Yrs)
9.294800E-01
Normal-vs-Age(61-80Yrs)
4.291000E-01
Normal-vs-Age(81-100Yrs)
6.736000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.440000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.158800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.433600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.317000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.783600E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.433800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.333580E-01
Normal-vs-Daily Drinker
1.377560E-01
Normal-vs-Weekly Drinker
4.699800E-01
Normal-vs-Occasional Drinker
8.770600E-01
Normal-vs-Social Drinker
9.450200E-01
Non Drinker-vs-Daily Drinker
8.614200E-01
Non Drinker-vs-Weekly Drinker
3.349800E-01
Non Drinker-vs-Occasional Drinker
3.500400E-02
Non Drinker-vs-Social Drinker
2.570000E-02
Daily Drinker-vs-Weekly Drinker
4.209800E-01
Daily Drinker-vs-Occasional Drinker
4.405800E-02
Daily Drinker-vs-Social Drinker
7.098500E-02
Weekly Drinker-vs-Occasional Drinker
2.116000E-01
Weekly Drinker-vs-Social Drinker
3.195400E-01
Occasional Drinker-vs-Social Drinker
6.899200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.752800E-01
Normal-vs-Grade 2
9.649400E-01
Normal-vs-Grade 3
9.640600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.519800E-01
Grade 1-vs-Grade 3
4.749800E-01
Grade 1-vs-Grade 4
8.752800E-01
Grade 2-vs-Grade 3
7.756600E-01
Grade 2-vs-Grade 4
9.649400E-01
Grade 3-vs-Grade 4
9.640600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.367400E-01
Normal-vs-NonDiabetic
5.827600E-01
Diabetic-vs-NonDiabetic
3.511000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.410400E-01
Normal-vs-NoPancreatitis
5.572800E-01
Pancreatitis-vs-NoPancreatitis
6.037000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.556600E-01
Normal-vs-N1
4.744000E-01
N0-vs-N1
4.498000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.639600E-01
Normal-vs-TP53-NonMutant
9.318200E-01
TP53-Mutant-vs-TP53-NonMutant
1.282110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
